CVC Technologies (4744) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 皇將

CVC Technologies (4744) reported revenue of NT$145.3 million for Oct 2026, +100.8% year on year and +34.8% from the previous month. Revenue for Jan–Oct 2026 was NT$811.9 million (-16.5% year on year).

In Oct 2026, it ranked No. 57 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$75.4 million24/10Nov 2024 NT$113 millionDec 2024 NT$310.2 millionJan 2025 NT$31.1 millionFeb 2025 NT$42.3 million25/02Mar 2025 NT$207.8 millionApr 2025 NT$68.5 millionMay 2025 NT$49.3 millionJun 2025 NT$250.7 million25/06Jul 2025 NT$56.5 millionAug 2025 NT$67.3 millionSep 2025 NT$126.2 millionOct 2025 NT$72.4 million25/10Nov 2025 NT$122.2 millionDec 2025 NT$350.4 millionJan 2026 NT$66.3 millionFeb 2026 NT$28.3 million26/02Mar 2026 NT$145.4 millionApr 2026 NT$49.6 millionMay 2026 NT$62.1 millionJun 2026 NT$79.3 million26/06Jul 2026 NT$37.2 millionAug 2026 NT$90.6 millionSep 2026 NT$107.8 millionOct 2026 NT$145.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$145.3 million+100.8%+34.8%
Sep 2026NT$107.8 million-14.6%+19.0%
Aug 2026NT$90.6 million+34.6%+143.6%
Jul 2026NT$37.2 million-34.2%-53.1%
Jun 2026NT$79.3 million-68.4%+27.7%
May 2026NT$62.1 million+25.8%+25.1%
Apr 2026NT$49.6 million-27.5%-65.9%
Mar 2026NT$145.4 million-30.1%+413.2%
Feb 2026NT$28.3 million-33.0%-57.3%
Jan 2026NT$66.3 million+112.9%-81.1%
Dec 2025NT$350.4 million+13.0%+186.8%
Nov 2025NT$122.2 million+8.1%+68.8%
Oct 2025NT$72.4 million-4.0%-42.7%
Sep 2025NT$126.2 million+77.5%+87.4%
Aug 2025NT$67.3 million-25.9%+19.1%
Jul 2025NT$56.5 million-21.3%-77.5%
Jun 2025NT$250.7 million+132.7%+408.0%
May 2025NT$49.3 million-54.1%-27.9%
Apr 2025NT$68.5 million-21.1%-67.1%
Mar 2025NT$207.8 million+83.2%+391.3%
Feb 2025NT$42.3 million+16.6%+35.9%
Jan 2025NT$31.1 million-69.9%-90.0%
Dec 2024NT$310.2 million+33.5%+174.5%
Nov 2024NT$113 million+4.6%+49.9%
Oct 2024NT$75.4 million-12.7%+6.0%

Jan–Oct 2026 cumulative: NT$811.9 million (-16.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: CVC Technologies vs PEC / CVC Technologies vs Lotus Pharm / CVC Technologies vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本期銷售組合較多連線設備,導致營收增加。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16